Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Enovis Corp (ENOV)

Enovis Corp (ENOV)
43.45 +0.74 (+1.73%) 13:11 ET [NYSE]
43.41 x 72 43.49 x 105
Realtime by (Cboe BZX)
43.41 x 72 43.49 x 105
Realtime - - (-) -
Quote Overview for Mon, Feb 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
42.40
Day High
43.69
Open 42.67
Previous Close 42.71 42.71
Volume 206,822 206,822
Avg Vol 541,475 541,475
Stochastic %K 16.24% 16.24%
Weighted Alpha -24.31 -24.31
5-Day Change -0.44 (-1.00%) -0.44 (-1.00%)
52-Week Range 38.27 - 63.96 38.27 - 63.96
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,428,448
  • Shares Outstanding, K 56,859
  • Annual Sales, $ 1,707 M
  • Annual Income, $ -33,260 K
  • EBIT $ 43 M
  • EBITDA $ 260 M
  • 60-Month Beta 1.94
  • Price/Sales 1.17
  • Price/Cash Flow 6.68
  • Price/Book 0.72

Options Overview Details

View History
  • Implied Volatility 50.23% ( -13.83%)
  • Historical Volatility 29.32%
  • IV Percentile 76%
  • IV Rank 61.93%
  • IV High 68.07% on 10/16/24
  • IV Low 21.22% on 05/16/24
  • Put/Call Vol Ratio 0.47
  • Today's Volume 22
  • Volume Avg (30-Day) 382
  • Put/Call OI Ratio 4.97
  • Today's Open Interest 7,755
  • Open Int (30-Day) 7,383

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.92
  • Number of Estimates 4
  • High Estimate 0.95
  • Low Estimate 0.90
  • Prior Year 0.79
  • Growth Rate Est. (year over year) +16.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
42.38 +2.52%
on 02/21/25
Period Open: 47.79
49.38 -12.01%
on 01/27/25
-4.34 (-9.08%)
since 01/24/25
3-Month
41.71 +4.17%
on 12/19/24
Period Open: 46.67
49.75 -12.66%
on 12/04/24
-3.22 (-6.90%)
since 11/22/24
52-Week
38.27 +13.54%
on 10/08/24
Period Open: 62.85
63.96 -32.07%
on 03/07/24
-19.40 (-30.87%)
since 02/23/24

Most Recent Stories

More News
Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26th

ENOV : 43.44 (+1.71%)
Zacks Industry Outlook Enovis, Omnicell and Phreesia

For Immediate ReleaseChicago, IL – January 24, 2025 – Today, Zacks Equity Research Equity are Enovis ENOV, Omnicell OMCL and Phreesia PHR.Industry: Medical Info SystemsLink: https://www.zacks.com/commentary/2402288/3-medical-info-systems-stocks-to-buy-as-stargate-ai-drives-industry-prospectsStarting...

ENOV : 43.44 (+1.71%)
OMCL : 39.49 (-0.58%)
PHR : 28.24 (+0.07%)
3 Medical Info Systems Stocks to Buy as Stargate AI Drives Industry Prospects

Starting from healthcare resource management to efficient handling of medical records and patient data, the Medical Info Systems industry is rapidly expanding its boundaries with each passing day. Added...

ENOV : 43.44 (+1.71%)
OMCL : 39.49 (-0.58%)
PHR : 28.24 (+0.07%)
Enovis™ Announces Leadership Change to International Surgical Business

ENOV : 43.44 (+1.71%)
Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

ENOV : 43.44 (+1.71%)
Enovis Corporation Management to Participate in Upcoming Investor Conferences

Enovis Corporation executives will present at upcoming investor conferences, discussing their innovative medical technology solutions.Quiver AI SummaryEnovis Corporation, a medical technology growth company,...

ENOV : 43.44 (+1.71%)
Enovis to Participate in Upcoming Investor Conferences

ENOV : 43.44 (+1.71%)
Enovis Announces Third Quarter 2024 Results

ENOV : 43.44 (+1.71%)
Enovis to Host Third Quarter 2024 Results Conference Call on November 6th

ENOV : 43.44 (+1.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.

See More

Key Turning Points

3rd Resistance Point 45.35
2nd Resistance Point 44.69
1st Resistance Point 43.70
Last Price 43.44
1st Support Level 42.05
2nd Support Level 41.39
3rd Support Level 40.40

See More

52-Week High 63.96
Fibonacci 61.8% 54.15
Fibonacci 50% 51.11
Fibonacci 38.2% 48.08
Last Price 43.44
52-Week Low 38.27

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Mastering Fibonacci: The Hidden Order in Market Movements